1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MGAT4B CTRPv2 pan-cancer AAC -0.17 1e-05
mRNA ACTN4 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA C15orf38-AP3S2 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA NHLRC1 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA PLK4 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA CENPV CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA GNS CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA CEP162 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA RPF2 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA EFEMP1 CTRPv2 pan-cancer AAC -0.15 2e-05
Download CSV